Skip to main contentSkip to navigation
Sirius Investors

2664.T Stock: Cawachi Limited Stock Price, Analysis & Insights

Get live 2664.T stock price $3510.00, comprehensive Cawachi Limited stock analysis, charts, news, and expert forecast. Real-time 2664.T stock data and investment insights.

3510.00
1.89%Today
2664.TCawachi Limited • Tokyo Stock Exchange • Healthcare
Market Cap
78.39B
Volume
101.50K
52W High
3545.00
52W Low
2728.00

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Cawachi Limited is a prominent Japanese company that operates a network of drugstores throughout the nation. Its retail offerings encompass a diverse range of products, including pharmaceutical goods, health and wellness foods, childcare necessities,...

Company Information

CEO
Shinji Kawachi
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
2722

Contact Information

Address
1293 Soshima
Country
JP

Investment Analysis & Business Insights

Healthcare
Medical - Pharmaceuticals

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 24.5)

Lower volatility stock (Beta: 0.18) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Cawachi Limited shareholders
  • Market volatility can significantly impact stock price, especially for mid-cap stocks
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Cawachi Limited
  • Investors should consider how Cawachi Limited fits within their overall portfolio allocation

Market Cap

78.39B

P/E Ratio (TTM)

24.49

Beta

0.18

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

43/100 ⭐⭐⭐

Overall
-1.0%
NYSE
-1.6%
NASDAQ
-0.4%
Sector1D1W1MP/EScore
Financial Services+0.3%+1.3%+1.9%19.8
83/100⭐⭐⭐⭐⭐
Technology+0.8%+1.1%+3.0%52.0
76/100⭐⭐⭐⭐⭐
Basic Materials+0.8%+0.3%+1.9%27.9
69/100⭐⭐⭐⭐
Industrials-0.3%-0.9%+2.7%43.0
64/100⭐⭐⭐⭐
Communication Services-0.8%-1.3%+0.4%21.9
48/100⭐⭐⭐
Consumer Defensive+0.6%+1.6%-2.5%31.2
44/100⭐⭐⭐
Healthcare-1.0%-2.0%+1.5%30.5
43/100⭐⭐⭐
Real Estate+0.5%-1.1%-0.0%50.0
33/100⭐⭐
Energy+0.5%-3.6%-0.0%35.9
31/100⭐⭐
Utilities+2.0%-1.3%-5.1%26.1
31/100⭐⭐
Consumer Cyclical-0.3%+0.3%-0.2%55.8
28/100⭐⭐

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-06-13.